-
1
-
-
33846380861
-
Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes
-
DOI 10.1016/j.bbagen.2006.09.019, PII S0304416506002959
-
Kirchheiner J, Seeringer A. Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes. Biochim Biophys Acta 2007;1770:489-94. (Pubitemid 46136751)
-
(2007)
Biochimica et Biophysica Acta - General Subjects
, vol.1770
, Issue.3
, pp. 489-494
-
-
Kirchheiner, J.1
Seeringer, A.2
-
2
-
-
0037362122
-
Implications of pharmacogenetics for individualizing drug treatment and for study design
-
Meisel C, Gerloff T, Kirchheiner J, et al. Implications of pharmacogenetics for individualizing drug treatment and for study design. J Mol Med 2003;81:154-67. (Pubitemid 36470182)
-
(2003)
Journal of Molecular Medicine
, vol.81
, Issue.3
, pp. 154-167
-
-
Meisel, C.1
Gerloff, T.2
Kirchheiner, J.3
Mrozikiewicz, P.M.4
Niewinski, P.5
Brockmoller, J.6
Roots, I.7
-
3
-
-
7544219932
-
Pharmacogenetics-based new therapeutic concepts
-
DOI 10.1081/DMR-200033458
-
Roots I, Gerloff T, Meisel C, et al. Pharmacogenetics-based new therapeutic concepts. Drug Metab Rev 2004;36:617-38. (Pubitemid 39453066)
-
(2004)
Drug Metabolism Reviews
, vol.36
, Issue.3-4
, pp. 617-638
-
-
Roots, I.1
Gerloff, T.2
Meisel, C.3
Kirchheiner, J.4
Goldammer, M.5
Kaiser, R.6
Laschinski, G.7
Brockmoller, J.8
Cascorbi, I.9
Kleeberg, U.10
Hildebrandt, A.G.11
-
4
-
-
4544312379
-
Phenobarbital for the treatment of epilepsy in the 21st century: A critical review
-
DOI 10.1111/j.0013-9580.2004.12704.x
-
Kwan P, Brodie MJ. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004;45:1141-9. (Pubitemid 39238126)
-
(2004)
Epilepsia
, vol.45
, Issue.9
, pp. 1141-1149
-
-
Kwan, P.1
Brodie, M.J.2
-
5
-
-
45749150011
-
Antiepileptic drugs - Best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
-
DOI 10.1111/j.1528-1167.2008.01561.x
-
Patsalos PN, Berry DJ, Bourgeois BF, et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008;49:1239-76. (Pubitemid 351991390)
-
(2008)
Epilepsia
, vol.49
, Issue.7
, pp. 1239-1276
-
-
Patsalos, P.N.1
Berry, D.J.2
Bourgeois, B.F.D.3
Cloyd, J.C.4
Glauser, T.A.5
Johannessen, S.I.6
Leppik, I.E.7
Tomson, T.8
Perucca, E.9
-
6
-
-
33847137375
-
Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese
-
DOI 10.1097/FTD.0b013e318030def0, PII 0000769120070200000017
-
Goto S, Seo T, Murata T, et al. Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese. Ther Drug Monit 2007;29:118-21. (Pubitemid 46279885)
-
(2007)
Therapeutic Drug Monitoring
, vol.29
, Issue.1
, pp. 118-121
-
-
Goto, S.1
Seo, T.2
Murata, T.3
Nakada, N.4
Ueda, N.5
Ishitsu, T.6
Nakagawa, K.7
-
7
-
-
0034037772
-
CYP2C19 polymorphism effect on phenobarbitone. Pharmacokineties in Japanese patients with epilepsy: Analysis by population pharmacokinetics
-
Mamiya K, Hadama A, Yukawa E, et al. CYP2C19 polymorphism effect on phenobarbitone. Pharmacokinetics in Japanese patients with epilepsy: analysis by population pharmacokinetics. Eur J Clin Pharmacol 2000;55:821-5. (Pubitemid 30201764)
-
(2000)
European Journal of Clinical Pharmacology
, vol.55
, Issue.11-12
, pp. 821-825
-
-
Mamiya, K.1
Hadama, A.2
Yukawa, E.3
Ieiri, I.4
Otsubo, K.5
Ninomiya, H.6
Tashiro, N.7
Higuchi, S.8
-
8
-
-
0025951584
-
Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age
-
Ratanasavanh D, Beaune P, Morel F, et al. Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatology 1991;13:1142-51.
-
(1991)
Hepatology
, vol.13
, pp. 1142-1151
-
-
Ratanasavanh, D.1
Beaune, P.2
Morel, F.3
-
9
-
-
34547638113
-
Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life
-
DOI 10.1358/mf.2007.29.4.1106408
-
Allegaert K, Verbesselt R, Rayyan M, et al. Urinary metabolites to assess in vivo ontogeny of hepatic drug metabolism in early neonatal life. Methods Find Exp Clin Pharmacol 2007;29:251-6. (Pubitemid 47204045)
-
(2007)
Methods and Findings in Experimental and Clinical Pharmacology
, vol.29
, Issue.4
, pp. 251-256
-
-
Allegaert, K.1
Verbesselt, R.2
Rayyan, M.3
Debeer, A.4
De Hoon, J.5
-
10
-
-
0025820318
-
Differential foetal development of the O- And N-demethylation of codeine and dextromethorphan in man
-
Ladona MG, Lindström B, Thyr C, et al. Differential foetal development of the O- and N-demethylation of codeine and dextromethorphan in man. Br J Clin Pharmacol 1991;32:295-302.
-
(1991)
Br J Clin Pharmacol
, vol.32
, pp. 295-302
-
-
Ladona, M.G.1
Lindström, B.2
Thyr, C.3
-
12
-
-
1342344547
-
Developmental Expression of Human Hepatic CYP2C9 and CYP2C19
-
DOI 10.1124/jpet.103.060137
-
Koukouritaki SB, Manro JR, Marsh SA, et al. Developmental expression of human hepatic CYP2C9 and CYP2C19. J Pharmacol Exp Ther 2004;308:965-74. (Pubitemid 38263972)
-
(2004)
Journal of Pharmacology and Experimental Therapeutics
, vol.308
, Issue.3
, pp. 965-974
-
-
Koukouritaki, S.B.1
Manro, J.R.2
Marsh, S.A.3
Stevens, J.C.4
Rettie, A.E.5
McCarver, D.G.6
Hines, R.N.7
-
13
-
-
13444256073
-
Ontogeny of drug metabolizing enzymes in the neonate
-
DOI 10.1016/j.siny.2004.11.001, Perinatal Pharmacology
-
Blake MJ, Castro L, Leeder JS, et al. Ontogeny of drug metabolizing enzymes in the neonate. Semin Fetal Neonatal Med 2005;10:123-38. (Pubitemid 40215540)
-
(2005)
Seminars in Fetal and Neonatal Medicine
, vol.10
, Issue.2
, pp. 123-138
-
-
Blake, M.J.1
Castro, L.2
Leeder, J.S.3
Kearns, G.L.4
-
14
-
-
0036396419
-
Ontogeny of hepatic and renal systemic clearance pathways in infants: Part II
-
Alcorn J, McNamara PJ. Ontogeny of hepatic and renal systemic clearance pathways in infants: part II. Clin Pharmacokinet 2002;41:1077-94. (Pubitemid 35251856)
-
(2002)
Clinical Pharmacokinetics
, vol.41
, Issue.13
, pp. 1077-1094
-
-
Alcorn, J.1
McNamara, P.J.2
-
15
-
-
0033727389
-
Clinical pharmacokinetics of phenobarbital in neonates
-
Touw DJ, Graafland O, Cranendonk A, et al. Clinical pharmacokinetics of phenobarbital in neonates. Eur J Pharm Sci 2000;12:111-16.
-
(2000)
Eur J Pharm Sci
, vol.12
, pp. 111-116
-
-
Touw, D.J.1
Graafland, O.2
Cranendonk, A.3
-
16
-
-
23944435458
-
PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM
-
DOI 10.1016/j.cmpb.2005.04.005, PII S016926070500101X
-
Lindbom L, Pihlgren P, Jonsson EN, et al. PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 2005;79:241-57. (Pubitemid 41196689)
-
(2005)
Computer Methods and Programs in Biomedicine
, vol.79
, Issue.3
, pp. 241-257
-
-
Lindbom, L.1
Pihlgren, P.2
Jonsson, N.3
-
17
-
-
0017346481
-
Metabolic fate of phenobarbital. A quatitative study of p hydroxyphenobarbital elimination in man
-
Whyte MP, Dekaban AS. Metabolic fate of phenobarbital. A quantitative study of p-hydroxyphenobarbital elimination in man. Drug Metab Dispos 1977;5:63-70. (Pubitemid 8040983)
-
(1977)
Drug Metabolism and Disposition
, vol.5
, Issue.1
, pp. 63-70
-
-
Whyte, M.P.1
Dekaban, A.S.2
-
18
-
-
0027320235
-
Dosage programming of phenobarbital in neonatal seizures
-
Alonso Gonzalez AC, Ortega Valin L, Santos Buelga D, et al. Dosage programming of phenobarbital in neonatal seizures. J Clin Pharm Ther 1993;18:267-70. (Pubitemid 23235094)
-
(1993)
Journal of Clinical Pharmacy and Therapeutics
, vol.18
, Issue.4
, pp. 267-270
-
-
Alonso, G.A.C.1
Ortega, V.L.2
Santos, B.D.3
Garcia, S.M.J.4
Santos, B.J.5
Monzon, C.L.6
Dominguez-Gil, H.A.7
-
19
-
-
0017662568
-
Pharmacokinetics of phenobarbital in childhood
-
Heimann G, Gladtke E. Pharmacokinetics of phenobarbital in childhood. Eur J Clin Pharmacol 1977;12:305-10.
-
(1977)
Eur J Clin Pharmacol
, vol.12
, pp. 305-310
-
-
Heimann, G.1
Gladtke, E.2
-
21
-
-
34248146195
-
Determinants of drug metabolism in early neonatal life
-
Allegaert K, van den Anker JN, Naulaers G, et al. Determinants of drug metabolism in early neonatal life. Curr Clin Pharmacol 2007;2:23-9. (Pubitemid 46723127)
-
(2007)
Current Clinical Pharmacology
, vol.2
, Issue.1
, pp. 23-29
-
-
Allegaert, K.1
Van Den, A.J.N.2
Naulaers, G.3
De Hoon, J.4
|